ASP Isotopes Inc.

NasdaqCM:ASPI Stock Report

Market Cap: US$1.0b

ASP Isotopes Future Growth

Future criteria checks 2/6

ASP Isotopes is forecast to grow earnings and revenue by 43.5% and 49.3% per annum respectively while EPS is expected to grow by 53.6% per annum.

Key information

43.5%

Earnings growth rate

53.58%

EPS growth rate

Chemicals earnings growth17.3%
Revenue growth rate49.3%
Future return on equityn/a
Analyst coverage

Low

Last updated03 Jun 2026

Recent future growth updates

Recent updates

Seeking Alpha • May 28

ASP Isotopes: The Long Road From Isotopes To Income

Summary ASP Isotopes (ASPI) is rated Sell due to premature growth narrative, high capital intensity, and heavy execution risk versus current $6.89 share price. My DCF valuation implies a $2.40 fair value, reflecting the need for ASPI to prove commercial scale, margin conversion, and financing capacity. Recent business updates show segment progress—radiopharma leads revenue, Si-28 and Yb-176 shipments targeted for 2026, and Renergen Phase 1 drilling completed early. Despite $290.5M liquidity, ASPI faces negative cash flow, widening losses, and a 25% probability of failure, making current risk-reward unattractive. Read the full article on Seeking Alpha
Seeking Alpha • Jan 25

ASP Isotopes: Too Hot To Handle

Summary ASP Isotopes Inc. is rated a sell for retail value investors due to price volatility, significant losses, heavy spending on SG&A over R&D, and other risks. The company’s dilution of shareholders and increasing debt are red flags. ASP’s small workforce and high market cap raise concerns, especially given the competitive landscape. Company operations are in South Africa and Iceland, hardly known for their high-tech product market share and tech workforces. Read the full article on Seeking Alpha

Earnings and Revenue Growth Forecasts

NasdaqCM:ASPI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2028257-90N/AN/A2
12/31/202788-119-24-143
12/31/202630-58-74-601
3/31/202627-193-66-52N/A
12/31/202524-175-47-38N/A
9/30/20258-106-34-24N/A
6/30/20255-100-31-20N/A
3/31/20254-37-29-17N/A
12/31/20244-35-28-17N/A
9/30/20243-30-24-15N/A
6/30/20242-27-16-11N/A
3/31/20241-20-10-7N/A
12/31/20230-16-8-5N/A
9/30/2023N/A-13-6-4N/A
6/30/2023N/A-11-8-4N/A
3/31/2023N/A-8-8-4N/A
12/31/2022N/A-5-7-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ASPI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ASPI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ASPI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ASPI's revenue (49.3% per year) is forecast to grow faster than the US market (12.1% per year).

High Growth Revenue: ASPI's revenue (49.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ASPI's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/03 14:47
End of Day Share Price 2026/06/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ASP Isotopes Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
George GianarikasCanaccord Genuity
null nullCantor Fitzgerald & Co.
Derek SoderbergCantor Fitzgerald & Co.